This inventor holds 1 USPTO granted patent. Top assignees: Senseion Therapeutics, Inc., Washington University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1,383 
Years Active: 2026
Title: Daniel Lerner: Inventor in Inflammasome Research
Introduction
Daniel Lerner is an inventor associated with St. Louis, Missouri. His work includes a patent concerning methods for suppressing inflammasome activation and addressing conditions in which inflammation contributes to disease.
Latest Patents
Lerner is associated with 1 patent, titled “Suppression of Inflammasome Activation.” The invention describes methods for suppressing inflammasome activation, including approaches to treating diseases or conditions in which inflammation contributes to the disease state.
Career Highlights
Lerner has been associated with Washington University and Senseion Therapeutics, Inc. His patent reflects work focused on inflammation and potential therapeutic approaches.
Collaborations
His named collaborators include Rajan Sah and Hongzhen Hu.
Conclusion
Daniel Lerner’s patent work centers on suppressing inflammasome activation, with a focus on conditions in which inflammation plays a role.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile